13
Participants
Start Date
November 10, 2017
Primary Completion Date
October 29, 2018
Study Completion Date
October 29, 2018
JTE-051
Active drug tablets containing JTE-051
Placebo
Placebo tablets identical in appearance to the active drug tablets
Forest Hills Dermatology Group, Forest Hills
Clinical Research Center of the Carolinas, Charleston
Radiant Research, Inc., Anderson
Atlanta Dermatology Vein and Research Center LLC, Alpharetta
Advanced Medical Research, PC, Sandy Springs
University of South Florida - Hospital, Tampa
Clinical Research Advantage, Inc., Evansville
Dermatology Treatment and Research Center, Dallas
Advanced Clinical Research - Dermatology Center of Canyon County, Nampa
First OC Dermatology, Fountain Valley
Center For Dermatology Clinical Research, Inc., Fremont
Kansas City Dermatology P.A., Overland Park
Karma Clinical Trials, St. John's
Mediprobe Research Inc., London
Lynderm Research Inc., Markham
David Gratton's Private Practice, Montreal
Lead Sponsor
Akros Pharma Inc.
INDUSTRY